Carbon nanotubes: properties, synthesis, purification, and medical applications A Eatemadi, H Daraee, H Karimkhanloo, M Kouhi, N Zarghami, ... Nanoscale research letters 9, 1-13, 2014 | 1429 | 2014 |
WNT1 gene from WNT signaling pathway is a direct target of miR-122 in hepatocellular carcinoma Z Ahsani, S Mohammadi-Yeganeh, V Kia, H Karimkhanloo, N Zarghami, ... Applied biochemistry and biotechnology 181, 884-897, 2017 | 59 | 2017 |
Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma H Karimkhanloo, S Mohammadi-Yeganeh, Z Ahsani, M Paryan Tumor Biology 39 (4), 1010428317698361, 2017 | 26 | 2017 |
Deep proteomic profiling unveils arylsulfatase A as a non-alcoholic steatohepatitis inducible hepatokine and regulator of glycemic control MK Montgomery, J Bayliss, S Nie, W De Nardo, SN Keenan, PM Miotto, ... Nature Communications 13 (1), 1259, 2022 | 19 | 2022 |
Mouse strain-dependent variation in metabolic associated fatty liver disease (MAFLD): a comprehensive resource tool for pre-clinical studies H Karimkhanloo, SN Keenan, J Bayliss, W De Nardo, PM Miotto, ... Scientific reports 13 (1), 4711, 2023 | 13 | 2023 |
Circulating cathepsin S improves glycaemic control in mice H Karimkhanloo, SN Keenan, EW Sun, DA Wattchow, DJ Keating, ... Journal of Endocrinology 248 (2), 167-179, 2021 | 11 | 2021 |
Western diet induced remodelling of the tongue proteome M Dutt, YK Ng, J Molendijk, H Karimkhanloo, L Liao, R Blazev, ... Proteomes 9 (2), 22, 2021 | 10 | 2021 |
Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma H Karimkhanloo, S Mohammadi-Yeganeh, R Hadavi, A Koochaki, ... Molecular Biology Reports 47 (10), 7429-7437, 2020 | 9 | 2020 |
Bioinformatic investigation of mirnas involved in the regulation of beta-catenin and cyclin D1 expression H Karimkhanloo, M Paryan, M Darabi, S Mohamadi-Yeganeh, Z Ahsani INTERNATIONAL JOURNAL OF ADVANCED BIOTECHNOLOGY AND RESEARCH 7 (2), 701-709, 2016 | 2 | 2016 |
Lipidome profiling in advanced metabolic liver disease identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism M Anari, H Karimkhanloo, S Nie, L Dong, G Fidelito, J Bayliss, SN Keenan, ... Cell Reports 43 (12), 2024 | | 2024 |
Understanding metabolic and endocrine dysregulation in non-alcoholic fatty liver disease (NAFLD) H Karimkhanloo Monash University, 0 | | |